Cliical Trials: Multiplicity & Subgroup Analyses

Planning and Interpreting Subgroup Analyses—Without P-Hacking Planning and Interpreting Subgroup Analyses—Without P-Hacking Subgroup analyses play a critical role in clinical trials, providing insight into the variability of treatment effects across different patient populations. However, these analyses must be approached with caution to avoid misleading conclusions or “P-hacking,” a practice that can undermine the integrity of…

Read More “Planning and Interpreting Subgroup Analyses—Without P-Hacking” »

Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods In the landscape of clinical research and trials, managing the statistical challenges related to multiple comparisons is crucial for maintaining the integrity and validity of the conclusions drawn from trial data. This article serves as a comprehensive step-by-step guide aiming to…

Read More “Gatekeeping, Bonferroni and Other Multiplicity Adjustment Methods” »

Hierarchical Testing Strategies for Primary and Secondary Endpoints Hierarchical Testing Strategies for Primary and Secondary Endpoints In the realm of clinical research and trials, addressing multiplicity—specifically in the context of primary and secondary endpoints—is vital for ensuring robust statistical results and regulatory compliance. This tutorial provides a comprehensive step-by-step guide tailored for clinical operations, regulatory…

Read More “Hierarchical Testing Strategies for Primary and Secondary Endpoints” »

Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs In the realm of clinical research and trials, managing multiplicity effectively is essential for ensuring the reliability and validity of trial outcomes. This article aims to provide a comprehensive guide for professionals in clinical operations,…

Read More “Managing Multiplicity: Controlling Type I Error in Complex Clinical Programs” »

Regulatory Expectations on Claims Based on Subgroup Findings In the ever-evolving landscape of clinical trials, subgroup analyses play an essential role in understanding the nuanced effects of treatments across different patient demographics. However, with the advantages provided by such analyses come significant regulatory expectations. This guide aims to elucidate best practices and recommendations for conducting…

Read More “Regulatory Expectations on Claims Based on Subgroup Findings” »

Visualizing Subgroup Results for Clinicians, Executives, and Regulators In clinical research, performing effective subgroup analyses is crucial for understanding how different segments of a population respond to an intervention. This is particularly relevant for trials assessing therapeutic options with varied mechanisms of action and diverse participant demographics. Visualizations serve as powerful tools for conveying complex…

Read More “Visualizing Subgroup Results for Clinicians, Executives and Regulators” »

Multiplicity in Platform, Basket and Umbrella Trials Multiplicity in Platform, Basket and Umbrella Trials Multiplicity in clinical trials presents a unique challenge, particularly within the frameworks of platform, basket, and umbrella studies. Understanding how to manage these challenges is vital for ensuring regulatory compliance and scientific integrity. This guide presents a comprehensive tutorial for clinical…

Read More “Multiplicity in Platform, Basket and Umbrella Trials” »

Graphical Approaches to Multiple Testing in Modern Trial Designs Introduction to Multiple Testing in Clinical Trials Multiple testing in clinical trials is a rigorous and essential component of biostatistical analysis that helps ensure the integrity and reliability of trial outcomes. When conducting clinical trials, the primary goal is to establish the efficacy and safety of…

Read More “Graphical Approaches to Multiple Testing in Modern Trial Designs” »

Pre-Specifying Subgroup Analyses in Protocol and SAP for Regulatory Trust In the realm of clinical research, the rigorous evaluation of treatments through patient enrollment in clinical trials is paramount for evidence-based decision-making. One critical aspect that demands careful consideration is the pre-specification of subgroup analyses in the clinical trial protocol and the statistical analysis plan…

Read More “Pre-Specifying Subgroup Analyses in Protocol and SAP for Regulatory Trust” »